麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida鈥檚 KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida鈥檚 KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 28 2016

Full Issue

The Odd Silence From Patient Advocacy Groups On Drug Prices

News outlets report on stories related to pharmaceutical drug pricing.

Public anger over the cost of drugs has burned hot for a year, coursing through social media, popping up on the presidential campaign, and erupting in a series of congressional hearings, including one last week over the rising price of the allergy treatment EpiPen. But one set of voices has been oddly muted 鈥 the nation鈥檚 biggest patient advocacy groups. The groups wield multimillion-dollar budgets and influence on Capitol Hill, but they have been largely absent in the public debate over pricing. (Thomas, 9/27)

Even in an age when prescription drugs are increasingly expensive, a $9,500 tube of gel to combat scaly skin can gain notice 鈥 especially when the price spikes 128 percent overnight. That鈥檚 what happened earlier this month when a little-known company called Novum Pharma suddenly hiked wholesale prices for all three of its dermatology products by whopping amounts. (Silverman, 9/23)

A Chicago-based pharmaceutical company that's selling skin medications for thousands of dollars is the latest to take heat in the nationwide furor over drug pricing. (Schencker, 9/26)

With EpiPens and other prescription drugs rising in cost, families who desperately need them but do not have health insurance are bearing a huge financial burden, according to community advocates. The Maryland Citizens鈥 Health Initiative, a coalition of more than 1,200 religious, labor, business and policy groups seeking quality and affordable health care, wants the state legislature to address that financial burden by overhauling some of the laws governing drug pricing. (Escobar, 9/27)

The California Drug Price Relief Act would require the state to pay no more for prescription drugs than the Department of Veterans Affairs pays聽for the same medication. The federal agency negotiates drug prices with pharmaceutical companies, paying on average one-quarter less for drugs than other government agencies. The poll shows support for Proposition 61 is broad-based. Subgroups of likely voters most in favor include Democrats, liberals, voters in the nine-county Bay Area and Los Angeles County, college graduates, those under age 30 and Latinos. (Seipel, 9/24)

Does having your medication mailed to your door sound appealing? The discounts are often significant, especially for drugs that people take regularly, such as those for diabetes and high blood pressure. You might be able to order a three-month supply for a co-payment of just a few dollars. In some cases, you might be eligible to get generic medications with no co-pay at all, and free shipping. In addition, of course, there鈥檚 no need for you to go to a drugstore. (9/23)

Sen. Amy Klobuchar (D-Minn.) on Monday laid out several paths forward for drug price legislation, though she said any movement could be dependent on a 鈥渢rigger moment.鈥 Possible vehicles, she said, include the prescription drug user fee agreement that must be passed next year, the 21st Century Cures Act, tax reform and reforms to the Affordable Care Act. Legislation could also pass as a package of pharmaceutical price reforms. (Owens, 9/26)

Mylan raised EpiPen鈥檚 鈥渢o get filthy rich at the expense of our constituents,鈥 [Maryland Representative Elijah] Cummings said. Their strategy was to 鈥渇ind an old cheap drug that has virtually no competition and raise the price over and over and over again as high as you can.鈥 (Rood, 9/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优